Jan Frystyk

Palle Juul Jensens Boulevard 165
Aarhus N, 8200, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 191 publications

Lifelong congenital untreated isolated GH deficiency does not alter human leukocyte telomere length.

Lifelong congenital untreated isolated GH deficiency does not alter human leukocyte telomere length.

Journal: Journal of endocrinological investigation

Published: April 17, 2026

Prospective Short- and Long-Term Changes in Cardiometabolic Risk Markers Following Gender-Affirming Hormone Therapy.

Prospective Short- and Long-Term Changes in Cardiometabolic Risk Markers Following Gender-Affirming Hormone Therapy.

Journal: Andrology

Published: January 27, 2026

Improved quality of life with semaglutide in schizophrenia: Secondary analyses from a randomized controlled trial.

Improved quality of life with semaglutide in schizophrenia: Secondary analyses from a randomized controlled trial.

Journal: Schizophrenia research

Published: November 14, 2025

IGF-I bioavailability in congenital isolated growth hormone deficiency.

IGF-I bioavailability in congenital isolated growth hormone deficiency.

Journal: European journal of endocrinology

Published: October 21, 2025

IGF-PAPP-A-stanniocalcin axis and androgenic anabolic steroid use in men and women.

IGF-PAPP-A-stanniocalcin axis and androgenic anabolic steroid use in men and women.

Journal: European journal of endocrinology

Published: October 16, 2025

Semaglutide Effects on Insulin Sensitivity and β-Cell Function in Patients With Schizophrenia, Prediabetes, and Obesity Treated With Second-Generation Antipsychotics: Findings From the HISTORI Trial, a 30-Week Randomized, Placebo-Controlled Trial With Semaglutide 1.0 mg Weekly.

Semaglutide Effects on Insulin Sensitivity and β-Cell Function in Patients With Schizophrenia, Prediabetes, and Obesity Treated With Second-Generation Antipsychotics: Findings From the HISTORI Trial, a 30-Week Randomized, Placebo-Controlled Trial With Semaglutide 1.0 mg Weekly.

Journal: Diabetes care

Published: September 04, 2025

Semaglutide Treatment of Antipsychotic-Treated Patients With Schizophrenia, Prediabetes, and Obesity: The HISTORI Randomized Clinical Trial.

Semaglutide Treatment of Antipsychotic-Treated Patients With Schizophrenia, Prediabetes, and Obesity: The HISTORI Randomized Clinical Trial.

Journal: JAMA psychiatry

Published: September 03, 2025

Illicit Anabolic Steroid Use and Cardiovascular Status in Men and Women.

Illicit Anabolic Steroid Use and Cardiovascular Status in Men and Women.

Journal: JAMA network open

Published: August 29, 2025

Bioactive IGF-I Concentrations in Children on GH Therapy.

Bioactive IGF-I Concentrations in Children on GH Therapy.

Journal: The Journal of clinical endocrinology and metabolism

Published: August 27, 2025

Cardiac autonomic neuropathy in patients with SGA-treated schizophrenia: a randomized controlled trial of 30 weeks' treatment with semaglutide.

Cardiac autonomic neuropathy in patients with SGA-treated schizophrenia: a randomized controlled trial of 30 weeks' treatment with semaglutide.

Journal: Cardiovascular diabetology. Endocrinology reports

Published: July 20, 2025

Muscle Strength and Power Changes With Gender-Affirming Hormone Therapy.

Muscle Strength and Power Changes With Gender-Affirming Hormone Therapy.

Journal: Andrology

Published: June 08, 2025

Muscle strength changes and physical activity during gender-affirming hormone therapy: A systematic review.

Muscle strength changes and physical activity during gender-affirming hormone therapy: A systematic review.

Journal: Andrology

Published: February 27, 2025

Showing 1-12 of 191

Last Updated: 09/26/2026